Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias
Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias
Multiple myeloma highlights and more from ASH 2018
Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia
Developments in CAR T treatments for adult patients
ASH 2018: Expert overview of the latest in CLL, ALL and AML
Determining the prognosis of patients with myelodysplastic syndromes using machine learning
Link between gut microbiota and haematopoietic cell transplantation outcomes
New therapies for transfusion dependent MDS patients
Cancer care in areas of drug conflict
Cancer control in small island developing states
The best way to collaborate
Developing global curricula for cancer control